You can buy or sell Vaxart and other stocks, options, ETFs, and crypto commission-free!
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. Read More The company was founded in 2004 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Vaxart says potential COVID-19 vaccine picked for 'Operation Warp Speed'
(Reuters) - Vaxart Inc said on Friday it would test its experimental oral COVID-19 vaccine on monkeys infected with the new coronavirus in a study funded by the
— per share
Expected Aug 6, After Hours